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Control of aldosterone responsiveness in terminal renal failure.
Plasma aldosterone concentration in 30 hemodialysis patients
correlated closely with renin concentration, renin activity or
renin and potassium concentrations combined (r 0.62; P <
0.01), and increased consistently in response to upright posture
or corticotropin administration. Aldosterone response to hemo-
dialysis was variable. Significant correlations (r 0.65; P <0.01)
were demonstrated between postural plasma aldosterone and
renin responses, between aldosterone responses to corticotropin
and basal plasma aldosterone or renin and potassium values,
between hemodialysis-induced changes in plasma aldosterone
and those in potassium or renin; but not between various indexes
of heparin treatment and aldosterone activity. Bilateral nephrec-
tomy reduced basal plasma renin and aldosterone concentrations
and aldosterone responsiveness in five preoperatively normore-
ninemic or hyperreninemic patients, but not in a hyporeninemic
patient. These results demonstrate the complementary roles of
circulating renin and potassium in the control of aldosterone re-
lease under basal and stimulatory conditions in patients with
terminal renal failure. Administration of heparin in dosages
used during long-term hemodialysis does not appear to signi-
ficantly interfere with aldosterone control.
L'aldosterone et l'insuffisance rénale chronique. La concentra-
tion plasmatique de l'aldostérone, chez 30 malades soumis a
l'hémodialyse, est étroitement corrélée avec Ia concentration
de refine, l'activité de Ia refine et les niveaux combines de
rénine et de potassium (r 0,62; P <0,01). La concentration
d'aldostérone est significativement augmentée par Ia position
debout ou I'administration de corticotrophine. La réponse
de l'aldostérone a l'hémodialyse est variable. Des corréla-
tions significatives (r? 0,65; P< 0,01) existent entre les réponses
de l'aldostérone et de Ia refine aux modifications posturales,
entre les responses de I'aldostérone a Ia corticotrophine et les
valeurs basales de l'aldostérone plasmatique ou les valeurs de Ia
rénine et du potassium, entre les modifications de l'aldostérone
plasmatique induites par l'hémodialyse et celles du potassium ou
de Ia refine. II n'y a pas de correlations entre divers paramétres
du traitement héparinique et l'activité de l'aldostérone. La
néphrectomie bilatérale réduit les valeurs basales de Ia rénine et
de I'aldostérone et réduit le potentiel de réponse de l'aldostérone
chez cinq malades dont Ia rénine, avant l'intervention était nor-
male ou élevée. Cette reduction n'est pas observée chez un malade
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dont Ia rénine était normale avant l'intervention. Ces résultats
démontrent les roles complémentaires de Ia rénine et du potassi-
um plasmatiques dans le contrôle de Ia liberation d'aldostérone
dans les conditions basales ou de stimulation chez des malades
atteints d'insuffisance rénale terminale. L'héparine, aux doses
utilisées au cours de l'hemodialyse iterative, ne parait pas inter-
fOrer significativement avec le contrOle de l'aklostérone.
Because of the known role of the renin-angiotensin-
aldosterone system in the regulation of blood pressure
and electrolyte metabolism [1, 2], it is important to
assess the functional status of this system in uremic
patients, who are especially prone to aberrations of
blood pressure and electrolyte regulation [3—6]. In a
previous study from this laboratory, it was concluded
that in patients with terminal renal failure basal plasma
aldosterone concentrations are largely regulated by
the complementary effects of the renin-angiotensin
system and potassium, the former remaining an im-
portant factor despite greatly reduced renal mass [7].
The present report describes the second part of this
work in which different renin and aldosterone method-
ology and a new population of 30 hemodialysis
patients were used to evaluate aldosterone responsive-
ness to acute stimuli in such patients. This was done
by studying the effects of upright posture, hemodialysis
and infusions of adrenocorticotropic hormone on
plasma aldosterone concentration in nonnephrecto-
mized hemodialysis patients. In addition, the role of
the kidney in aldosterone responsiveness was further
evaluated in a selected group of patients by performing
hemodialysis or corticotropin-i nfusion studies before
and after bilateral nephrectomy.
Methods
Thirty patients were studied, 25 men and 5 women
with an age range of 22 to 65 yr. Thirteen patients had
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glomerulonephritis, six had pyelonephritis or obstruc-
tive uropathy or both, four had nephrosclerosis, three
had polycystic kidney disease, one had medullary
cystic kidney disease, one had radiation nephritis and
in two patients no definite renal diagnosis was made.
All patients were in terminal renal failure treated with
maintenance hemodialysis. The dialysate contained
0 to 2 mEq/liter of potassium and 132 mEq/liter of
sodium. The total duration of hemodialysis treatment
in these patients ranged from 0.5 to 89 months.
Seventeen patients had hypertension (> 140/90mm Hg)
and 13 had a normal blood pressure. Twelve of the 17
hypertensive patients were studied after discontinua-
tion of blood pressure-lowering drugs; and in 5 anti-
hypertensive treatment was not interrupted.
All 30 patients were studied in the nonnephrecto-
mized state. Weight, blood pressure and plasma
concentrations of sodium, potassium, aldosterone and
plasma renin activity, and serum renin concentration
were measured under the following conditions: 1)
after one hour in the supine position, and following
one hour in the upright position with ambulation
(17 patients); 2) before and immediately after hemo-
dialysis while in the supine position (19 patients); and
3) before, and after one and two hours of an in-
fusion of a synthetic adrenocorticotropic hormone;
(Cortrosyn, Organon, Inc.) at a rate of 0.1 mg
(approximately 10 USP units of ACTH) per hour (17
patients). In the corticotropin infusion studies, plasma
cortisol concentrations were also measured.
In six patients who underwent bilateral nephrec-
tomy, the postural or corticotropin studies or both
were repeated in the anephric state. The interval
between the prenephrectomy or postnephrectomy
studies and surgery was always less than four weeks
and the test conditions were kept constant. Each
patient gave his informed consent before undergoing
any of the studies.
Plasma sodium and potassium concentrations were
determined by a flame photometer (Instrumentation
Laboratory). Plasma renin activity and serum renin
concentration were measured by radioimmunoassays,
using the method of Haber et al [8] and a modification
of the method of Gould, Skeggs and Kahn [9]. In our
laboratory, the normal ranges of plasma renin activity
during a sodium intake of 120 mEq/day are 90 to
640 ng/100 ml/3 hr in the supine and 175 to 1200 ng/
100 ml/3 hr in the upright position (original method of
Haber with incubation pH of 7.4). The respective
normal ranges for serum renin concentration are 5 to
35 ng/ml/16 hr in the supine and 15 to 75 ng/ml/l6 hr
in the upright position [10]. Plasma aldosterone con-
centration was measured by the radioimmunoassay
method of Ito et al [11]. On the basis of previous [11]
as well as extensive additional studies in our laboratory
[10], the following normal ranges (sodium intake of
120 mEq/day) are now used with this method: supine
position, 1.6 to 8.4 ng/100 ml; upright position, 3.2 to
26.0 ng/lOO ml; infusion of corticotropin (0.1 mg/hr)
for one hour, 4.8 to 20.4 ng/l00 ml, and for two hours,
5.0 to 28.3 ng/100 ml. Plasma cortisol concentration
was measured by competitive protein binding assay
[121.
A paired data t test was used for the statistical
analysis of measurements done before and after the
different test procedures. The natural logarithms of
plasma renin activity, serum renin concentration and
plasma aldosterone values were used for the statistical
analysis.
Results
Studies in nonnephrectomized hemodialysis patients.
1) Basal conditions. Supine plasma aldosterone con-
centrations in nonnephrectomized hemodialysis
patients correlated significantly with serum renin
concentration (N 29; r = 0.62; P <0.001), plasma
renin activity (N==43; r=0.67; P<0.001) or plasma
renin activity and potassium concentrations combined
(N=43; r=0.68; P<0.001). In contrast, there was no
significant correlation between basal plasma aldo-
sterone concentrations and plasma sodium or indexes
of heparin treatment such as the duration of mainte-
nance hemodialysis, the average amount of heparin
given per dialysis (40 to 140 mg) or per week (120 to
420 mg) or the interval since the previous dialysis.
2) Effect of upright posture (Table 1). Mean plasma
aldosterone concentration increased from 12.4
14.7 (SD) ng/100 ml during recumbency to 26.3
27.7 ng/lOO ml following active standing for one hour
(P.<0.001). The postural increases in plasma aldo-
sterone correlated significantly with a) basal plasma
aldosterone (r=0.66; P<0.005), renin activity (r=
0.54; P<0.05), or renin activity and potassium levels
combined (r=0.54; P <0.05); and b) with the accom-
panying increases in serum renin concentration
(r=0.82; P<0.001) or plasma renin activity (r=0.75;
P <0.001), but not with any of the parameters of
heparin treatment mentioned above. Mean plasma
potassium and sodium levels and mean blood pressure
remained unchanged following assumption of the
upright posture.
3) Effect of hemodialysis (Table 2, Fig. 1). The 19
patients in whom hemodialysis studies were per-
formed could be divided into three groups according
to their renin and aldosterone responses (Table 2).
Following hemodialysis, seven patients showed an
increase in both plasma renin and aldosterone con-
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Table 1. Effects of upright posture on plasma aldosterone, renin, electrolytes and mean blood pressure in nonnephrectomized
hemodialysis patients
Patient
No.
Aldosterone
ng/100 ml
Sa
Renin activity
ng/JOO ml
S
con
S
Renin
centration
ng/ml
Ub
Potassium
mEq/liter
S U5
Sodium
mEqiliter
S U5
Blood pressure
mm Hg
Sa US
2 10.7 51.9 5130 6590 287 359 3.9 4.4 138 134 154 153
3 7.7 8.7 1480 2120 38 63 4.7 5.1 138 136 149 149
4 2.4 5.2 37 46 9 14 5.8 6.2 133 133 151 159
5 18.5 73.5 3395 4690 462 593 4.4 5.2 132 129 148 154
6 4.6 5.7 365 490 25 35 4.3 4.3 130 130 135 157
8 39.8 51.2 280 350 34 50 5.5 5.7 138 137 116 123
9 51.6 85.0 1385 1740 68 147 6.9 6.6 142 141 125 100
10 4.1 25.4 2180 2290 91 113 5.5 5.8 138 136 114 135
11 16.2 23.0 115 210 13 36 5.8 5.4 131 131 89 94
12 29.9 65.0 860 1110 23 24 5.2 5.3 138 138 95 97
13 2.0 3.0 6 10 2 3 5.3 5.1 134 134 105 97
I4' 4.6 5.1 580 570 47 57 6.6 6.6 140 141 100 100
J5C 6.5 9.2 350 325 32 21 4.9 5.0 138 138 128 93
16e 3.1 8.6 170 250 10 13 5.5 5.0 133 137 113 109
17 5.6 17.3 690 970 31 37 5.1 4.9 134 135 80 70
IS 2.2 5.0 840 1185 45 63 3,7 3.7 135 134 83 81
19c 2.0 3.6 335 345 26 30 5.4 5.9 140 140 133 128
Mean 12.4 26.3 1070 1370 73.1 97.5 5.14 5.26 136.0 135.5 119 118
su 14.7 27.7 1369 1783 119.6 152.7 0.87 0.76 3.5 3.2 24 29
P <0.001 <0.001 <0.001 NS NS + NS
S=supine.
' U=upright.
During treatment with methyldopa and/or propranolol and hydralazine.
centrations (group A), eight demonstrated renin-
aldosterone dissociation with increased plasma renin
and decreased or unchanged aldosterone values
(group B) and four showed decreased plasma renin
and aldosterone concentrations (group C).
Under basal condition, plasma renin, aldosterone
and electrolyte levels varied considerably within each
group, without consistent significant differences
among groups. Mean plasma potassium concentra-
tions in groups A, B and C were 4.8 5.3
and 5.5 1.0 mEq/liter, respectively, and mean plasma
sodium concentrations were 136±4, 135±3 and
137 3 mEq/liter, respectively. Mean basal blood
pressure was higher in group A (P < 0.001) and group
C (not significant) than in group B. Accordingly,
group A and C patients underwent generally more
vigorous ultrafiltration during dialysis resulting in
slightly greater mean decreases in body and plasma
sodium concentration in these subjects as compared to
group B patients. However, significantly different
responses (other than plasma renin or aldosterone
responses) to hemodialysis were found only in regard
to plasma potassium concentrations which decreased
more in groups B (P<0.02) and C (P<0.05) than in
group A.
Single regression analysis of the hemodialysis-
induced alterations in all patients showed significant
correlations between the changes in plasma aldo-
sterone and those in plasma potassium (r=0.80;
P<0.001), renin concentration (r=0.59; P<0.01) or
renin activity (r=0.65; P<0.005) (Fig. 1). Multiple
correlation of the changes in aldosterone on the
changes in potassium and renin activity combined
showed a correlation coefficient of 0.66 (P <0.005) and
+20 .
is is0o o
—10 .
o 0
-20
E —30 NI9
=O65
—40 Peso'
—50 ng/lOOml
—2500 0 +2500 +7500
A Plasma renin activity
+30
+20
+10
..
0
—TO
—20
—30
•
N=19
s-so
—40 P<OOI
50 mEq/liter
—3.0 —2.0 —1.0
A Plasma potassium
Fig. 1. Correlations between changes in plas,na aldosterone and
changes in plasma renin activity or potassium concentration
following hemodialysis in nonnephrectomized hemodialysis
patients.
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Table 2. Effect of hemodialysis on plasma aldosterone, renin and electrolyte levels, and on body weight and mean blood pressure
in nonnephrectomized patients
Patient Aldosterone Renin activity Renin A Potas- A Sodium A Body Blood pressure
No. ng/100 ml ng/100 ml concentration sium mEqiliter wt mm Hg
ng/ml mEq/liter kg
B' A'° B° Ab W Ab
B Ab
A) Patients with increased renin and aldosterone after dialysis
20.0 29.0 11177 14978 1180 1476 —0,7 —9 —4.20 166 165
2 10.7 32.8 5132 11764 287 560 —0.5 —6 —1.7 154 169
3 7,7 9.0 1479 3607 38 127 —1.0 —6 —0.4 149 136
4 2.4 3.6 37 49 9 10 —1.6 +1 —2.9 151 132
6 4.6 11.2 367 813 25 43 —0.9 —2.7 135 134
7 4.3 6.2 750 800 — — —1.8 —4 —1.8 131 144
10 4.1 4.5 2180 2675 91 101 —1.6 —1 —1.2 114 85
Mean 7.7 13.8 3017 4955 271 386 —1.2 —3.6 —2.1 143 138
SD 6.1 12.0 3983 5949 457 570 0.5 3.7 1.2 17 28
P <0.02 <0.02 <0.05 <0.0025 <0.05 <0.0025 NS
B) Patients with increased renin and decreased or unchanged aldosterone after dialysis
8 39.8 25.8 280 1360 34 53 —1.8 +2 —2.7 116 113
11 16.2 1.3 115 375 13 13 —2.4 +3 —0.7 89 69
13 2.0 2.0 6 21 2 2 — 1,6 —1.3 105 100
14° 4.6 2.3 580 725 47 74 —1.6 —1 100 107
15° 6.5 2.5 350 520 32 42 —1.7 —6 —0.1 128 95
16° 3.1 1.3 170 195 10 13 —2,0 +1 —0.9 113 113
17 5.6 3.6 690 800 31 30 —2.1 —4 —0.7 80 70
18 2.2 1.1 840 1300 45 65 —0.9 —4 —1.3 83 81
Mean 10.0 5.0 379 662 27 37 —1.8 —1.1 —1.0 102 94
SD 12.9 8.4 296 485 17 26 0.4 3.2 0.9 17 18
P <0.02 <0.02 <0.02 <0.001 NS <0,002 NS
C) Patients with decreased renin and aldosterone after dialysis
5 18.5 8.0 3395 1955 462 348 —1.2 +2 —2.8 148 151
9 51.6 7.8 2745 1385 147 103 —2.9 —4 —1.0 125 57
12° 29.9 2.4 860 795 23 31 —2.1 —4 +0.3 95 87
19 2.0 1.6 335 275 30 28 —1.7 —6.5 133 123
Mean 25.5 5.0 1834 1102 206 128 —2.0 —1.5 —2.5 125 105
SD 20.8 3.4 1468 727 166 151 0,7 3.0 3.0 22 41
a B=before dialysis.
b A=after dialysis.
During treatment with methyldopa and/or propranolol and hydralazine.
the correlation coefficient of changes in aldosterone
on changes in potassium and renin concentration com-
bined was 0.68 (P < 0.005).
4) Effect of corticotropin administration (Table 3).
Corticotropin consistently caused distinct increases in
plasma aldosterone concentration, which rose from a
mean control value of 6.3 6.9 ng/l00 ml to 25.6
27.8 ng/100 ml (P <0.001) after one hour and to
27.5± 31.0 ng/lOO ml (P<0.00l) after two hours of
infusion. The magnitude of the aldosterone responses
correlated significantly with basal plasma aldosterone
(r =0.72;P <0.001) or renin activity (r =0.57;P <0.02),
or renin activity and potassium concentrations com-
bined (r=0.74; P< 0.001). These correlations are even
closer with the exclusion of a single statistical outlier
(patient 26) (r=0.88; P<0.00l, r=0.65; P'zzo.Ol and
r=0.80; P'zO.OOl, respectively). There was no rela-
tionship between aldosterone response to cortico-
tropin and indexes of heparin administration such as
total duration of hemodialysis, heparin dosage per
dialysis, or per week, or interval since previous dialysis
(Table 3).
Basal levels and responsiveness of plasma cortisol
were unremarkable. Mean plasma renin activity and
sodium concentrations and blood pressure did not
change significantly following corticotropin admini-
stration, while plasma potassium concentration was
slightly increased (P <0.05).
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Table 3. Effect of corticotropin administration on plasma aldosterone, cortisol, renin activity and potassium concentrations and mean blood
pressure in nonnephrectomized hemodialysis patients
Patient Interval Aldosterone Cortisol Renin activity Potassium Blood
No. since
previous
dialysis
ng/100 ml i.g/100 nil ng/100 ml mEg/liter pressure
mm Hg
days C 60" 120'" a 60'b 120'" C 120'" Ca 60'" 120'" Ca 120'c
9 2 1.9 23.7 19.0 22.6 36.6 44.4 360 515 4.3 5.0 5.3 97 103
11 1 9.! 50.0 50.0 26.9 38.5 39.5 385 415 4.8 5.4 5.6 82 83
12 2 7.9 50.0 31.9 12.3 22.1 34.5 330 295 6.0 5.0 5.4 90 95
13 2 0.5 1.4 1.5 20.6 26.6 29.3 45 40 4.6 4.7 4.7 107 107l4 3 2.9 6.3 13.0 15.4 24.0 31.5 575 635 6.3 7.0 7.1 101 100
16d 2 2.0 10.4 5.2 10.8 32.2 30.7 225 275 5.3 5.4 5.5 130 123
18 1 4.3 10.1 19.5 13.5 32.7 39.3 680 385 3.7 4.0 5.0 110 107
19" 2 2.5 9.6 11.6 22.2 25.8 35.5 430 420 4.7 4.7 4.6 113 107
20 1 1.2 5.4 4.8 5.5 7.5 8.5 1700 — 4.6 4.6 4.6 83 83
21 2 1.5 7.4 4.4 6.0 10.6 10.5 300° — 5.0 4.8 4.7 72 75
22 2 3.4 18.8 19.6 25.2 47.2 50.4 600 565 3.5 3.7 3.8 109 105
23 1 0.9 3.4 3.2 11.0 31.4 37.4 90° — 3.6 3.7 3.8 97 102
24 2 1.7 8.5 9.4 9.1 19.9 35.2 30 60 5.4 5.7 5.4 132 117
25 1 10.6 108.0 67.0 20.0 34.5 35.5 785 530 5.3 4.6 5.3 91 91
26 2 20.0 26.0 37.0 8.2 18.0 24.5 2820 1790 5.5 5.4 5.8 92 94
27 1 12.6 43.1 49.0 22.7 36.2 40.4 1890 1515 4.4 4.7 4.6 87 86
30 1 23.7 53.7 122.0 11.4 30.0 46.1 3320 3165 4.4 4.2 4.7 143 142
Mean 6.3 25.6 27.5 15.5 27.9 33.7 891 758 4.80 4.86 5.05 102 101
sD 6.9 27.8 31.0 7.0 10.2 11.1 1031 852 0.80 0.80 0.78 19 16
P <0.001 <0.001 <0.001 <0.001 NS NS <0.05 NS
a C=eontrol.
b 60'= following administration of corticotropin for one hour.
° 120'= following administration of corticotropin for two hours.
During treatment with methyldopa and/or propranolol and hydralazine.
° Not included in t test.
Studies before and after bilateral nephrectomy to low or subnormal levels (Fig. 2). This was associated
(Table 4, Fig. 2). In each of four patients studied, re- with a decrease of plasma renin activity to very low or
moval of the kidneys caused a substantial decrease in undetectable levels, while plasma sodium and potas-
pre- and postdialysis plasma aldosterone concentration sium concentrations were not changed significantly.
Table 4. Effects of bilateral nephrectomy on plasma aldosterone, cortisol and renin concentrations before and during corticotropin
administration
Patient Condition Interval Aldosterone Cortisol Renin activity Renin
No. since
previous
dialysis
days
ng/100 ml p.g/100 ml ng/100 ml
Ca 120'o
concentration
ng/ml
C 120"'C" 60'b 120'" a 60'b 120'"
13 Before Nx" 2 0.5 1.4 1.5 20.6 26.6 29.3 45 40 2 2
After Nx" 2 1.5 3.1 5.7 18.1 26.5 28.5 0 0 15 13
After Nx" 2 1.0 1.9 1.8 21.3 28.5 33.9 8 14 2 3
14 Before Nx"" 3 2.9 6.3 13.0 15.4 24.0 31.5 575 635 56 71
After Nx" 2 0.5 2.5 1.4 11.3 23.0 26.8 25 20 0 5
19 BeforeNx"'° 2 2.5 9.6 11.6 22.2 25.8 35.5 430 420 — —
After Nx" 2 0.5 3.9 3.7 23.2 32.2 34.8 17 18 0 0
30 Before Nx' 1 23.7 53.7 122.0 11.4 30.0 46.1 3320 3165 126 140
After Nx" 1 0.5 2.4 2,4 15.1 33.1 38.1 5 7 1 1
°C=control.
60'= following administration of corticotropin for one hour.
120' = following administration of corticotropin for two hours.
"Nx =bilateral nephrectomy.
During treatment with methyldopa and/or propranolol and hydralazine.
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Bilateral nephrectomy also reduced basal plasma
renin and aldosterone concentrations and aldosterone
responsiveness to corticotropin in each of three
patients (patients 14, 19 and 30) who had normal or
elevated plasma renin and aldosterone values and aldo-
sterone responsiveness before surgery. These nephrec-
tomy-induced decreases in aldosterone responsiveness
could not be related to differences in the interval
between the last hemodialysis and corticotropin in-
fusion.
In the fourth patient, nephrectomy had no consistent
effect on circulating renin or aldosterone responsive-
ness; this patient (patient 13) already had subnormal
plasma renin and aldosterone concentrations and a
weak aldosterone response to corticotropin administra-
tion before removal of his kidneys. Plasma cortisol
concentrations were not affected by nephrectomy and
there were no consistent changes in plasma sodium or
potassium concentrations.
Discussion
In this study in 30 nonnephrectomized hemodialysis
patients, the demonstration of a close relationship
between plasma aldosterone concentrations and the
circulating levels of both renin and potassium is con-
sistent with previous data from this [13] and another
laboratory [14].
One of the primary goals of this investigation was to
evaluate the effects of various stimuli of aldosterone
secretion in nonnephrectomized hemodialysis patients.
Williams et al [15] reported generally intact aldoster-
one responsiveness in nondialyzed patients with termi-
nal renal failure, but absent aldosterone responses to
upright posture in two of three, and to corticotropin
administration in three of six, hemodialysis patients.
They concluded that the altered adrenal function in
some of their hemodialysis patients was due to some
aspect of the dialysis procedure itself, possibly heparin,
which is known to possess aldosterone-inhibitory
potential [16, 17]. Tn the present investigation, the
change from the supine to the upright posture or the
infusion of corticotropin was found to cause distinct
increases in plasma aldosterone concentration in each
of the 34 studies in which these stimuli were evaluated.
If the heparin given during a hemodialysis acutely
interfered with aldosterone production, then the in-
terval between the end of the dialysis and blood samp-
ling would be of critical importance for determination
of aldosterone suppression. However, the differences
between the results of Williams et al [15], who per-
formed their studies on the day after dialysis, and our
data cannot be explained on this basis, since we found
equal aldosterone responsiveness to corticotropin
on the first and the second postdialysis days. Further-
more, the heparin doses which were initially shown
to inhibit aldosterone secretion [16, 17] were admini-
stered over several days and were much higher (200 to
300 mg/day) than the amounts which were infused
during only a few hours in our (40 to 140 mg) and
the patients of Williams et al (100mg). The demon-
stration of a) distinct aldosterone responsiveness
following long-term hemodialysis up to 90 months and
b) the absence of a relationship between basal levels
or responsiveness of plasma aldosterone and duration
of hemodialysis treatment, heparin dosage or interval
since the last dialysis in this study suggest that the
usual doses for heparinization during hemodialysis are
not sufficient to markedly interfere with aldosterone
secretion. This interpretation is also consistent with
previous experience in nonnephrectomized [7] or
anephric [18—20] hemodialysis patients.
Mean serum renin concentration, plasma renin ac-
tivity and aldosterone concentrations increased 33, 28
and ll2%, respectively, when the nonnephrectomized
patients changed from the supine to the upright posi-
tion. These postural responses appear somewhat
diminished since mean renin concentration and activ-
ity in a control group of 19 healthy subjects increased
more than twofold and plasma aldosterone about
threefold following one hour of standing [10].
Blunted postural renin responsiveness has also been
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Fig. 2. Effect of bilateral nephrectomy on predialysis and post-
dialysis levels of plasma aldosterane, renin and electrolytes in four
patients with terminal renal failure. Nx = nephrectomy, B = before
dialysis, A = after dialysis.
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noted by others in such patients [211. The present data
demonstrate a close significant correlation (P<0.0O1)
between postural renin and aldosterone responses, and
they suggest that diminished increases in plasma aldo-
sterone concentration in some of these patients prob-
ably reflect impaired renin release rather than adrenal
dysfunction due to a factor associated with uremia or
with the hemodialysis procedure.
Corticotropin administration stimulated mean
plasma aldosterone concentration fourfold in the non-
nephrectomized patients, but the individual values
varied between subnormal and increased responses.
Available experimental and clinical evidence indicates
that both potassium [19, 22, 23] and the renin-angio-
tensin system [24, 25] modulate aldosterone respon-
siveness to corticotropin. The present finding of a
closer correlation between aldosterone responses to
corticotropin and basal plasma renin and potassium
concentrations combined (r=0.74; P<0.001) than
between aldosterone responsiveness and circulating
renin activity alone (r0.57; P<0.02) extends these
observations. Our data suggest that abnormal aldo-
sterone responses to corticotropin in hemodialysis
patients can be largely explained by parallel changes in
the plasma concentrations of renin or potassium or
both.
The concept that these two factors may play im-
portant complementary roles in the regulation of basal
as well as stimulated aldosterone release in hemo-
dialysis patients is also supported by the demonstra-
tion of close significant correlations between hemo-
dialysis-induced changes in plasma aldosterone and
the effects of this procedure on circulating renin
(r=0.65; P<0.005) or potassium (r=0.80; P<0.001)
concentrations. Furthermore, our observations during
acute opposite alterations of these factors, e.g.,
simultaneous renin stimulation and potassium deple-
tion, suggest that either of the two factors may play
the dominant role, depending on the magnitude of the
changes in their activity. More specifically, hemo-
dialysis caused parallel increases in plasma renin and
aldosterone in seven patients in whom the mean cir-
culating renin activity increased 1938 2487 ng/lOOml
(+64%) and potassium fell 1.2±0.5 mEq/liter; in
contrast, eight patients who showed a significantly
greater decrease in mean plasma potassium concentra-
tion (1.8 mEq/liter; P<0.02) demonstrated a
renin-aldosterone dissociation with parallel decreases
in plasma potassium and aldosterone despite increased
renin concentrations (+283±352 ng/lOO ml, or 75%,
respectively).
Anephric subjects have been used as a model to
study aldosterone control in the absence of a function-
ing renin-angiotensin system. Several authors ob-
served frequent low basal concentrations and dimin-
ished aldosterone responsiveness to various stimuli in
such patients [7, 15, 17, 18, 25, 26]; others, however,
reported findings consistent with generally normal
aldosterone metabolism [27—29].
The present study provides a series of observations
before and after nephrectomy with each patient serving
as his own control. Bilateral nephrectomy lowered
basal plasma renin and aldosterone concentrations as
well as aldosterone responsiveness to hemodialysis or
corticotropin in each of seven studies in patients who
had normal or elevated basal plasma renin and aldo-
sterone values before this operation. In contrast, post-
nephrectomy aldosterone concentration and respon-
siveness to corticotropin were not decreased in a
patient who had subnormal plasma renin levels before
surgery. These results and those obtained in a simi-
larly controlled study [25] clearly demonstrate the
participation of even irreversibly damaged nonexcre-
tory kidneys in the control of aldosterone secretion.
Although additional factors cannot be excluded, this
role appears closely related to the activity of the renin-
angiotensin system.
At present there is little known about the quantitative
aspects of the interaction between angiotensin II and
potassium in the regulation of aldosterone release in
man. Studies in anephric patients have shown that
potassium may stimulate aldosterone secretion even in
the absence of measurable plasma renin activity [18,
19, 30]. However, certain findings suggest that renin
deficiency may interfere with the effects of potassium
on aldosterone production. The mean plasma aldo-
sterone concentration for a given potassium concentra-
tion was found to be significantly lower in anephric
subjects than in nonnephrectomized hemodialysis
patients [7], and certain anephric patients may show
persistently low or subnormal plasma aldosterone
concentrations even in the presence of hyperkalemia
[15, 19, 25]. In addition, aldosterone responses to
acute increases in plasma potassium were of markedly
lesser magnitude in anephric patients [19] than in nor-
mal subjects [31]. Finally, recent observations in
patients with only mild to moderate impairment in
renal function have shown that hyporeninemia per se
may cause hypoaldosteronism despite the presence of
hyperkalemia [32, 33]. The present results extend these
findings in support of the concept that renin de-
ficiency may significantly interfere with aldosterone
control.
In contrast to the frequent abnormalities in aldo-
sterone metabolism, cortisol secretion does not appear
to be notably influenced by the metabolic changes of
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uremia or factors associated with chronic hemodialysis.
This conclusion is supported by the present finding as
well as by several other studies in nonnephrectomized
[15, 25] or anephric patients [15, 18, 19, 27, 28].
Acknowledgments
This study was supported by Public Health Service
grant AM-05630, by grant 415-IG from the Los
Angeles County Heart Association and by University
Medical Research Foundation. Dr. Hirsch was a
research fellow of the Cedars-Sinai Nephrology
Training Grant AM05630 from the National Institute
of Health, Public Health Service. Dr. de Lima was
partly supported by Fundacao Amparo a Pesquisa de
Sao Paulo, Brazil. Miss Graciela Vega-Gomez and
Miss Margrit Stoll provided technical assistance. Drs.
Arthur Gordon, Martin Rosenblatt, Bernard Salick,
Robert Sanford and Alvin Sellers permitted the study
of patients under their care.
Reprint requests to Dr. Morton H. Maxwell, Cedars-Sinai
Medical Center, 8720 Beverly Boulevard, Los Angeles, California
90048, U.S.A.
References
I. DAVIS JO, LARAGH JH, DENTON DA, MULROw PJ, MASSON
NC: The renin-angiotensin-aldosterone system, in Renal
Hypertension, edited by PAGE IH, MCCUBBIN JW, Chicago,
Year Book Medical Publishers, 1968, P. 214
2. LARAGH JH: Vasoconstriction-volume analysis for under-
standing and treating hypertension: The use of renin and
aldosterone profiles. Am J Med 55:261—274, 1973
3. BROWN JJ, DUSTERDIECK G, FRASER R, LEVER AE, ROBERT-
SON JIS, TREE M, WEIR RT: Hypertension and chronic renal
failure. Br Med Bull 27:128—135, 1971
4. VORBURGER C: FlUssigkeits- und Elektrolytraume bei der
chronischen Niereninsuffizienz: Beziehungen zum Blutdruck
und zur Kohlenhydrattoleranz. He/v Med Acta 51:1—142,
1971
5. WEIDMANN P, MAXWELL MH, Luu AN, LEWIN AJ,
MASSRY SG: Plasma renin activity and blood pressure in
terminal renal failure. N Engi J Med 285:757—762, 1971
6. COLES GA: Body composition in chronic renal failure.
QJMed41:25-47, 1972
7. WEIDMANN P, MAXWELL MH, Luu AN: Plasma aldoster-
one in terminal renal failure. Ann Intern Med 78:13—18,
1973
8. HABER E, KOERNER T, PAGE LB, KLIMAN B, PURNODE A:
Application of a radioimmunossay for angiotensin I to the
physiologic measurements of plasma renin activity in normal
human subjects, J Cliii Endocrinol Metab 29:1349—1355,
1969
9. GOULD A, SKEGGS LT, KAHN JR: Measurement of renin
and substrate concentrations in human serum. Lab Invest 15:
1802—1813, 1966
10. WEIDMANN P, BURSZTEIN S, MAXWELL MH, DE LIMA J:
Effect of aging on plasma renin and aldosterone levels in
normal man, in Proc of the 7th Meet of the Am Soc of
Nephrol, Washington, Nov. 25 and 26, 1974, p. 98
11. ITO T, Woo J, HANING R, HORTON R: A radioimmunoassay
for aldosterone in human peripheral plasma including a
comparison of alternate techniques. J Clin Endocrinol
Metab 34:106—112, 1972
12. NUGENT CA, MAYES DM: Plasma cortical steroids deter-
mined by the use of cortical steroid-binding globulin and
dextran-coated charcoal. J Clin Endocrinol Metab 26:1116—
1122, 1966
13. WEIDMANN F, Luu AN, SCHROTH P, MAXWELL MH:
Plasma aldosterone in patients with end stage kidney
disease, in Proc of the European Dialysis Transplant Assoc,
edited by CAMERON JS, London, Pitman Medical, 1972,
pp. 147—1 53
14. VETTER W, ZARUBA K, ARMBRUSTER H, STREBEL U, BECKER-
HOFF R, SIEGENTHALER W: Plasma aldosterone during
hemodialysis in patients with terminal renal failure, in Proc
of the European Dialysis Transplant Assoc, edited by
CAMERON iS, London, Pitman Medical, 1973, pp. 332—340
15. WILLIAMS GH, BAILEY GL, HAMPERS CL, LAULER DP,
MERRTLL JP, UNDERWOOD RH, BLAIR-WEST JR, COGHLAN
JP, DENTON DA, SCOGGINS BA, WRIGHT RD: Studies on
the metabolism of aldosterone in chronic renal failure and
anephric man. Kidney mt 4:280—288, 1973
16. SCHLATMANN RJAFM, JANSEN AP, PRENEN H, VAN DER
KORST JK, MAJOOR CLH: The natriuretic and aldosterone-
suppressive action of heparin and some related polysulfated
polysaccharides. J Clin Endocrinol Metab 24:35—47, 1964
17. BAILEY RE, FORD HC: The effect of heparin on sodium
conservation and on the plasma concentration, the meta-
bolic clearance and the secretion and excretion rates of
aldosterone in normal subjects, Acta Endocrinol (Khh) 60:
249—264, 1969
18. BAYARD F, COOKE CR, TILLER DJ, BEITINS IZ, KOWARSKIA,
WALKER GT, MIGEON CJ: The regulation of aldosterone
secretion in anephric man. J Clin Invest 50:1585—1595, 1971
19. WEIDMANN F, HORTON R, MAXWELL MH, FRANKLIN SS,
FICHMAN M: Dynamic studies of aldosterone in anephric
man. Kidney mt 4:289—298, 1973
20. MCCAA RE, READ VH, COWLEY AW JR, BOWER JD, SMITH
GV, MCCAA CS: Influence of acute stimuli on plasma aldo-
sterone concentration in anephric man and kidney allograft
recipients. Circ Res 33:313—322, 1973
21. BLAUFOX MD, GOODMAN A, WESELEY S, SCHECHTER H,
WEINSTEIN E: The renin-angiotensin system in patients re-
ceiving chronic hemodialysis, in Control of Renin Secretion,
edited by ASSAYKEEN TA, New York, Plenum Press, 1972,
1972, p. 193
22. MULLER J: Steroidogenic effect of stimulators of aldosterone
biosynthesis upon separate zones of the rat adrenal cortex:
Influence of sodium and potassium deficiency. Eur J Clin
Invest 1:180—187, 1970
23. WILLIAMS GH, DLUHY RG, UNDERWOOD RH: The relation-
ship of dietary potassium intake to the aldosterone stimulat-
ing properties of ACTH. Clin Sci 39:489—496, 1970
24. GANONG WF, BORYCZKA AT, SHACKELFORD R: Effect of
renin on adrenocortical sensitivity to ACTH and angio-
tensin II in dogs. Endocrinology 80:703—706, 1967
25. GOODWIN TJ, JAMES VHT, PEART WS: The control of aldo-
sterone secretion in nephrectomized man. Clin Sci Molec
Med47:235—248, 1974
26. PEART WS: Renin and angiotensin in relation to aldosterone.
Am J Clin Pathol 54:324—330, 1970
27. MITRA 5, GENUTH SM, BERMAN LB, VERTES V: Aldosterone
secretion in anephric patients. N EngiJ Med 286:61—64, 1972
A ldosterone in terminal renal failure 359
28. MCCAA RE, MCCAA CS, READ DG, BOWER JD, GUYTON
AC: Increased plasma aldosterone concentration in response
to hemodialysis in nephrectomized man. Circ Res 31:473—
480, 1972
29, McCAA RE, BOWER JD, McC CS: Relative influence of
acute sodium and volume depletion on aldosterone secretion
in nephrectomized man. Circ Res 33:555—562, 1973
30. CooKE CR, RUIZ-MAZA F, KOWAR5KI A, MIGEON CJ,
WALKER GW: Regulation of plasma aldosterone concentra-
tion in anephric man and renal transplant recipients.
Kidney mt 3:160—166, 1973
31. DLUHY RG, AXELROD L, UNDERWOOD RH, WILLIAMS GH:
Studies of the control of plasma aldosterone concentration
in normal man: II. Effect of dietary potassium and acute
potassium infusion. J C/in Invest 51:1950—1957, 1972
32. SCI-LAMBELAN M, STOCKIGT JR, BIGLIERI EG: Isolated
aldosteronism in adults: A renin-deficiency syndrome. N
EngiJ Med 287:623—632, 1972
33. WEIDMANN P, REINHART R, MAXWELL MH, ROWE P,
COBURN JW, MASSRY SG: Syndrome of hyporeninernic
hypoaldosteronism and hyperkalemia in renal disease. J
C/in Endocrinol Metab 36:965—977, 1973
